Today: 9 June 2026
Home Depot stock ends 2025 lower as New Year shuts Wall Street; rates and February results in focus
1 January 2026
1 min read

Home Depot stock ends 2025 lower as New Year shuts Wall Street; rates and February results in focus

NEW YORK, January 1, 2026, 14:23 ET — Market closed.

Home Depot (HD) shares ended the final regular session of 2025 down 0.6% at $344.10, with U.S. stock markets closed on Thursday for the New Year’s Day holiday. The stock traded between $343.98 and $346.69 in the session.

The late-year dip matters because Home Depot is a bellwether for U.S. home improvement demand, which often tracks housing turnover and the cost of borrowing. With 2026 beginning, investors are looking for signs that easing rates translate into bigger renovation projects and higher spending per trip.

The broader market offered little support into year-end, with the S&P 500 down 0.74% on Dec. 31, while the Dow fell 0.63% and the Nasdaq slid 0.76%, Reuters reported. “It’s perfectly fine in any bull market to have moments of cost,” said Giuseppe Sette, co-founder and president of Reflexivity, pointing to profit-taking when liquidity is low. Reuters

Rival Lowe’s closed down 0.8% and building-products supplier Masco fell 1.2% in the same session.

In a Dec. 9 strategic update, The Home Depot reaffirmed its fiscal 2025 guidance and set a preliminary fiscal 2026 outlook. The company forecast total sales growth of about 2.5% to 4.5% and comparable sales — sales at stores open at least a year — flat to up 2%, with diluted earnings per share (EPS) seen flat to up 4%. It pegged the overall home improvement market at between a 1% contraction and 1% growth.

Comparable sales are a closely watched gauge because they strip out the impact of new store openings. EPS is a standard per-share profit metric used to compare companies across time and against analyst forecasts.

Home Depot has been pushing deeper into its “Pro” business — sales to professional contractors — while keeping a close eye on discretionary spending from do-it-yourself shoppers. Investors are watching whether any improvement in housing activity shows up first in Pro demand and bigger-ticket categories.

Before the next session, traders will focus on early-January U.S. data that can move bond yields and mortgage rates, including the ISM manufacturing PMI on Jan. 5 and the Employment Situation report for December on Jan. 9.

Policy watchers will also look ahead to the Federal Reserve’s Jan. 27–28 meeting, where any shift in the interest-rate outlook could ripple quickly through housing-related stocks.

For Home Depot, the next major company catalyst is its quarterly update, with earnings calendars expecting the next report around Feb. 24; the retailer has not yet listed upcoming events on its investor-relations page. Guidance for fiscal 2026 — and any color on Pro demand and larger projects — is likely to set the tone for the stock as 2026 trading gets underway.

Stock Market Today

  • Amgen (AMGN) Stock Analysis: Is It Still Undervalued After Strong Multi-Year Gains?
    June 9, 2026, 9:58 AM EDT. Amgen's stock has appreciated by 68.7% over five years, closing recently at $345.73. Despite robust share price gains, a Discounted Cash Flow (DCF) analysis indicates the stock is 48.3% undervalued, with an intrinsic value estimate of $668.86 per share based on projected future cash flows. The model uses Free Cash Flow to Equity, forecasting growth through 2035. Amgen trades at a price-to-earnings (P/E) ratio of 23.92x, reflecting market expectations for earnings and risk. Investors are reassessing Amgen's fair value amid its steady growth and large-cap biotechnology sector position, as it delivers a one-year return of 21.4%, slightly lagging peers. The findings suggest potential investment opportunities despite past strong performance.

Latest articles

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

9 June 2026
Regentis Biomaterials shares dipped 2 cents to $1.28 premarket after the company announced European surgeon training for its GelrinC knee implant will begin in Q3, marking a key commercial step but leaving investors waiting for revenue proof as the stock trades far below its $8 IPO price.
IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

9 June 2026
IREN surged 8.9% to $59.19 and was quoted higher premarket after a bitcoin rebound and renewed focus on its pivot to AI cloud infrastructure, but the stock remains exposed to bitcoin swings, heavy spending, and risks tied to its new 800MW South Australia data center project and major contracts with Nvidia and Microsoft.
AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

9 June 2026
AT&T shares edged up to $22.58 pre-market after reaffirming 2026 guidance and a $45B+ shareholder return plan, providing a cash-flow marker as satellite broadband competition looms; the stock remains pressured by SpaceX risks flagged by Oppenheimer, with second-quarter free cash flow seen at $4.0–$4.5B.
GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

9 June 2026
GSK will buy Nuvalent for $10.6 billion in cash, paying a 40% premium, to boost its oncology pipeline ahead of looming HIV drug patent expiries; Nuvalent shares jumped 38.9% premarket while GSK fell 1.4%, with the deal expected to add to GSK sales and profit from 2027 but dilute earnings per share 2026-2028 if it closes in Q3, and final outcome depends on FDA approvals and regulatory clearance.
EV Stocks Today: BYD’s weakest growth in five years and Tesla deliveries set up Friday’s trade
Previous Story

EV Stocks Today: BYD’s weakest growth in five years and Tesla deliveries set up Friday’s trade

No alien signal: most sensitive radio scan of interstellar comet 3I/ATLAS comes up empty
Next Story

No alien signal: most sensitive radio scan of interstellar comet 3I/ATLAS comes up empty

Go toTop